These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 29033565

  • 1. Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer.
    Ahmed MSU, Salam AB, Yates C, Willian K, Jaynes J, Turner T, Abdalla MO.
    Int J Nanomedicine; 2017; 12():6973-6984. PubMed ID: 29033565
    [Abstract] [Full Text] [Related]

  • 2. Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy.
    Abdalla MO, Karna P, Sajja HK, Mao H, Yates C, Turner T, Aneja R.
    J Control Release; 2011 Feb 10; 149(3):314-22. PubMed ID: 21047537
    [Abstract] [Full Text] [Related]

  • 3. Lipid-Based Nanocarrier by Targeting with LHRH Peptide: A Promising Approach for Prostate Cancer Radio-Imaging and Therapy.
    De K, Tanbir SKE, Sinha S, Mukhopadhyay S.
    Mol Pharm; 2024 Aug 05; 21(8):4128-4146. PubMed ID: 38920398
    [Abstract] [Full Text] [Related]

  • 4. Molecular MR Imaging of Prostate Cancer by Specified Iron Oxide Nanoparticles With PSMA-11 Peptides: A Preclinical Study.
    Ghorbani F, Aminzadeh B, Borji N, Soudmand S, Montazerabadi A.
    J Magn Reson Imaging; 2024 Jun 05; 59(6):2204-2214. PubMed ID: 37572082
    [Abstract] [Full Text] [Related]

  • 5. Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer.
    Miller-Kleinhenz J, Guo X, Qian W, Zhou H, Bozeman EN, Zhu L, Ji X, Wang YA, Styblo T, O'Regan R, Mao H, Yang L.
    Biomaterials; 2018 Jan 05; 152():47-62. PubMed ID: 29107218
    [Abstract] [Full Text] [Related]

  • 6. Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer.
    Yeh CY, Hsiao JK, Wang YP, Lan CH, Wu HC.
    Biomaterials; 2016 Aug 05; 99():1-15. PubMed ID: 27209258
    [Abstract] [Full Text] [Related]

  • 7. Drug/Dye-Loaded, Multifunctional PEG-Chitosan-Iron Oxide Nanocomposites for Methotraxate Synergistically Self-Targeted Cancer Therapy and Dual Model Imaging.
    Lin J, Li Y, Li Y, Wu H, Yu F, Zhou S, Xie L, Luo F, Lin C, Hou Z.
    ACS Appl Mater Interfaces; 2015 Jun 10; 7(22):11908-20. PubMed ID: 25978458
    [Abstract] [Full Text] [Related]

  • 8. Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T1/T2 Dual-Contrast Magnetic Resonance Imaging.
    Xiao S, Yu X, Zhang L, Zhang Y, Fan W, Sun T, Zhou C, Liu Y, Liu Y, Gong M, Zhang D.
    Int J Nanomedicine; 2019 Jun 10; 14():8499-8507. PubMed ID: 31695377
    [Abstract] [Full Text] [Related]

  • 9. Polymeric biocompatible iron oxide nanoparticles labeled with peptides for imaging in ovarian cancer.
    Shahdeo D, Roberts A, Kesarwani V, Horvat M, Chouhan RS, Gandhi S.
    Biosci Rep; 2022 Feb 25; 42(2):. PubMed ID: 35103283
    [Abstract] [Full Text] [Related]

  • 10. Folic acid on iron oxide nanoparticles: platform with high potential for simultaneous targeting, MRI detection and hyperthermia treatment of lymph node metastases of prostate cancer.
    Bonvin D, Bastiaansen JAM, Stuber M, Hofmann H, Mionić Ebersold M.
    Dalton Trans; 2017 Sep 26; 46(37):12692-12704. PubMed ID: 28914298
    [Abstract] [Full Text] [Related]

  • 11. PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer.
    Nagesh PKB, Johnson NR, Boya VKN, Chowdhury P, Othman SF, Khalilzad-Sharghi V, Hafeez BB, Ganju A, Khan S, Behrman SW, Zafar N, Chauhan SC, Jaggi M, Yallapu MM.
    Colloids Surf B Biointerfaces; 2016 Aug 01; 144():8-20. PubMed ID: 27058278
    [Abstract] [Full Text] [Related]

  • 12. Temperature-tunable iron oxide nanoparticles for remote-controlled drug release.
    Dani RK, Schumann C, Taratula O, Taratula O.
    AAPS PharmSciTech; 2014 Aug 01; 15(4):963-72. PubMed ID: 24821220
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of T2* Weighted MRI Imaging Sensitivity of U87MG Glioblastoma Cells Using γ-Ray Irradiated Low Molecular Weight Hyaluronic Acid-Conjugated Iron Nanoparticles.
    Huang HM, Wu PH, Chou PC, Hsiao WT, Wang HT, Chiang HP, Lee CM, Wang SH, Hsiao YC.
    Int J Nanomedicine; 2021 Aug 01; 16():3789-3802. PubMed ID: 34103915
    [Abstract] [Full Text] [Related]

  • 14. Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.
    Gao N, Bozeman EN, Qian W, Wang L, Chen H, Lipowska M, Staley CA, Wang YA, Mao H, Yang L.
    Theranostics; 2017 Aug 01; 7(6):1689-1704. PubMed ID: 28529645
    [Abstract] [Full Text] [Related]

  • 15. Gelatin-encapsulated iron oxide nanoparticles for platinum (IV) prodrug delivery, enzyme-stimulated release and MRI.
    Cheng Z, Dai Y, Kang X, Li C, Huang S, Lian H, Hou Z, Ma P, Lin J.
    Biomaterials; 2014 Aug 01; 35(24):6359-68. PubMed ID: 24816364
    [Abstract] [Full Text] [Related]

  • 16. Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells.
    Taratula O, Dani RK, Schumann C, Xu H, Wang A, Song H, Dhagat P, Taratula O.
    Int J Pharm; 2013 Dec 15; 458(1):169-80. PubMed ID: 24091153
    [Abstract] [Full Text] [Related]

  • 17. Cytotoxic effects and apoptosis induction of cisplatin-loaded iron oxide nanoparticles modified with chitosan in human breast cancer cells.
    Morovati A, Ahmadian S, Jafary H.
    Mol Biol Rep; 2019 Oct 15; 46(5):5033-5039. PubMed ID: 31278563
    [Abstract] [Full Text] [Related]

  • 18. Design of multifunctional magnetic iron oxide nanoparticles/mitoxantrone-loaded liposomes for both magnetic resonance imaging and targeted cancer therapy.
    He Y, Zhang L, Zhu D, Song C.
    Int J Nanomedicine; 2014 Oct 15; 9():4055-66. PubMed ID: 25187709
    [Abstract] [Full Text] [Related]

  • 19. Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models.
    Lugert S, Unterweger H, Mühlberger M, Janko C, Draack S, Ludwig F, Eberbeck D, Alexiou C, Friedrich RP.
    Int J Nanomedicine; 2019 Oct 15; 14():161-180. PubMed ID: 30613144
    [Abstract] [Full Text] [Related]

  • 20. Probing and Enhancing Ligand-Mediated Active Targeting of Tumors Using Sub-5 nm Ultrafine Iron Oxide Nanoparticles.
    Xu Y, Wu H, Huang J, Qian W, Martinson DE, Ji B, Li Y, Wang YA, Yang L, Mao H.
    Theranostics; 2020 Oct 15; 10(6):2479-2494. PubMed ID: 32194814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.